Intuitive Investments Group plc Investment in Midatech Pharma PLC (4860D)
29 Junio 2021 - 4:56AM
UK Regulatory
TIDMIIG
RNS Number : 4860D
Intuitive Investments Group plc
29 June 2021
29 June 2021
Intuitive Investments Group plc
Investment in Midatech Pharma PLC
Intuitive Investments Group plc (AIM: IIG) ("IIG" or the
"Company"), a closed-end investment company focussed on the life
sciences sector, announces an investment of GBP99,750 to acquire
350,000 ordinary shares of Midatech Pharma PLC (" Midatech ") at a
price of 28.5 pence per share (the "Investment"). The Investment is
part of Midatech 's fundraising as announced by Midatech on 29 June
2021 (the "Fundraising").
Midatech ( dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a
drug delivery technology company focussed on improving the
bio-delivery and bio-distribution of medicines. The Company
combines approved and development medications with its proprietary
and innovative drug delivery technologies to provide compelling
products that have the potential to powerfully impact the lives of
patients. Midatech reported a net loss from continuing operations
for the year ended 31 December 2020 of GBP22.2 million (which
includes non-cash impairment charges of GBP12.4 million), and, as
at 31 December 2020, had net assets of GBP6.7m. Further information
can be found on Midatech on its website www.midatechpharma.com
.
As part of the Fundraising, Robert Naylor, IIG's CEO, has
personally invested GBP242,250. David Evans, IIG's Chairman, has a
pre-existing interest of 400,000 warrants over Midatech's ordinary
shares. Accordingly, David Evans nor Robert Naylor voted as members
of the Investment Team approving the Investment.
For further information, please contact:
Intuitive Investments Group plc www.iigplc.com
David Evans, Executive Chairman Via Walbrook PR
Robert Naylor, CEO
Strand Hanson Limited - Nominated
Adviser +44 (0) 20 7409 3494
James Dance / James Bellman
Turner Pope Investments (TPI) Ltd
- Broker +44 (0) 20 3657 0050
Andrew Thacker / James Pope
Walbrook PR Limited - Media & Investor +44 (0)20 7933 8780 or intuitive@walbrookpr.com
Relations
+44 (0)7502 558 258 / +44 (0) 7980
Sam Allen / Paul McManus 541 893
About Intuitive Investments Group plc
The Company is a recently established investing company, seeking
to provide investors with exposure to a portfolio concentrating on
fast growing and/or high potential Life Sciences businesses
operating predominantly in the UK, continental Europe and the US,
utilising the Board's experience and in particular that of the
Chairman, David Evans, to seek to generate capital growth over the
long term for shareholders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQSEDSUUEFSEIM
(END) Dow Jones Newswires
June 29, 2021 05:56 ET (09:56 GMT)
Intuitive Investments (LSE:IIG)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Intuitive Investments (LSE:IIG)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024